Genosco Is A Clinical Stage Biotech Pursuing Discovery And Development Of Novel Small Molecule Drugs For Patients With Unmet Medical Needs Our Proprietary G Smarta C Platform Enables Discovery And Optimization Based On Rare Sequences In Protein Kinases That Can Be Targeted To Develop A Highly Selective Compound This Innovative Approach Has Enabled Us To Build A Strong Portfolio Of Multiple Independent And Partnered Pipelinesour Most Advanced Pipelinelazertinibis Currently Undergoing Phase 3 Global Clinical Trial By Janssen And Is Also Available In Korea For Patients With Egfrmnon Small Cell Lung Cancerrobust Research And Discovery Programs Are Also Underwaywith A Shared Mission To Enhance People S Lives Through Innovative Sciencewe Are United In Developing World Class Precision Medicine To Help People Have Healthier And Longer Livesour Interdisciplinary Team Consists Of Scientists With Deep Expertise In Medicinal Chemistrystructural & Computational Drug Discovery Designcell Biologypharmacologyand Drug Metabolism
No conferences found for this company.
| Company Name | Genosco Inc |
| Country |
United States
|
| Address | 767c Concord Avenue 1cambridge Ma 02138 |
| Telephone | Login to View |
| Login to View |
Enter your address and we will specify the offer for your area.